<DOC>
	<DOCNO>NCT00622011</DOCNO>
	<brief_summary>Delirium organic psychiatric syndrome characterize fluctuate consciousness impairment perception , cognition behavior . In hospitalized elderly , prevalence delirium range 10 % 40 % . If untreated , delirium associate significant morbidity mortality . Treatment delirium consist identify manage underlying medical abnormality associate psychiatric symptom . Conventional antipsychotic mainstay treatment agitation psychosis associate delirium ; use limit term EPS side effect . Second-generation antipsychotic agent report low incidence extrapyramidal side effect tardive dyskinesia result increase use treatment delirious patient . However , still consensus regard standard pharmacologic treatment syndrome take use second-generation antipsychotic agent account . Risperidone zotepine low incidence EPS effective treat disturb psychotic behavior . We hope compare efficacy safety risperidone zotepine treatment delirium correlation severity delirium autonomic dysfunction .</brief_summary>
	<brief_title>Risperidone Zotepine Treatment Delirium</brief_title>
	<detailed_description>Qualified inpatient enrol randomly give flexible-dose regimen Risperidone Zotepine . Autonomic dysfunction check use analysis heart rate variability active drug give . The initial start dose drug 1mg ( risperidone ) 50 mg ( zotepine ) day . The dosage increase depend status delirium first 7 day adjust patient maximally stabilize intolerable adverse event necessitated cessation . Risperidone zotepine taper 10 day patient consider stable . No concomitant psychotropic medication use study except lorazepam , give severe agitation insomnia . Patients assess another rater blind active drug time enrollment , subsequent 12 , 24 , assess daily discharge . The study period estimate around 12 month upon design number subject reach .</detailed_description>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Zotepine</mesh_term>
	<criteria>Patients may include study meet follow criterion : DSMIVTR delirium ( 293.0 delirium due general medical condition , 290.3 dementia delirium 290.41 , arteriosclerotic dementia delirium 780.09delirium NOS . 292.8 substanceinduced delirium ( exclude alcohol BZD ) Age 18 85 yearold inpatient ; either sex Patients able take Risperidone Zotepine orally Alcoholinduced delirium ; delirium cause seizure ; Sedative , hypnotic anxiolytic withdrawal delirium Patients schizophrenia bipolar disorder treat antipsychotic Patients mandatory take parenteral treatment Patients know allergic Risperidone Zotepine Women pregnancy lactation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>